跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
Irinotecan Hydrochloride Injection 40 mg/2 mL (15)
Approved
STANDARD
Irinotecan Hydrochloride Injection 40 mg/2 mL (15)
Pfizer (Perth) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
82034e49aa30542c
Company
Pfizer (Perth) Pty Ltd
Type
Standard
Approval Details
Approval Id
82034e49aa30542c
Product Name
Irinotecan Hydrochloride Injection 40 mg/2 mL (15)
Artg Id
405515
Artg Name
Irinotecan Hydrochloride Injection 40 mg/2 mL (15)
Sponsor
Pfizer (Perth) Pty Ltd
Company Detail Path
/organization/pfizer-perth-pty-ltd
Artg Date
2023-02-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
82034e49aa30542c
Type
Standard
Back to TGA Approvals
Irinotecan Hydrochloride Injection 40 mg/2 mL (15) - TGA Drug Approval Details
